Clinical Trial: BLOOM Study for Primary Sjogren’s Disease

Sjogren’s disease

The BLOOM clinical study is researching an investigational treatment to learn if it is safe and may help adults with symptoms of moderate to severe Sjogren’s Disease (SjD).

SjD is an autoimmune disease. It mainly affects glands in the body that produce moisture. Symptoms can include dry mouth, burning or itching eyes, and dry skin as well as joint pain and tiredness. There are currently no therapies approved specifically for Sjogren’s, so this study is exploring the potential of an injectable investigational treatment that may help manage symptoms.

The BLOOM Study is specifically for adults with primary Sjogren’s Disease, meaning that their disease developed on its own and is not the consequence of another disease.

Inclusion Criteria:

You may be able to take part if you:

• Are between 18 and 74 years old
• Have a diagnosis of primary Sjogren’s Disease for at least 1 year
• Are seropositive for antibodies to SSA/Ro at the Screening Visit
• Have not had a recent change to your treatment for primary Sjogren’s Disease (if you currently receive such treatment)
• Are not breastfeeding, pregnant, planning to become pregnant or get your partner pregnant during the study

Please note that additional criteria apply. The study doctor/staff can help you understand which criteria you need to meet to qualify for this study.

All study-related tests, examinations, and visits are provided at no cost to you. You may also be reimbursed for parking, travel, and meal expenses related to your study visits.

To learn more about the clinical research study, please click here.